33893239|t|Probing the binding specificities of human Siglecs by cell-based glycan arrays.
33893239|a|Siglecs are a family of sialic acid-binding receptors expressed by cells of the immune system and a few other cell types capable of modulating immune cell functions upon recognition of sialoglycan ligands. While human Siglecs primarily bind to sialic acid residues on diverse types of glycoproteins and glycolipids that constitute the sialome, their fine binding specificities for elaborated complex glycan structures and the contribution of the glycoconjugate and protein context for recognition of sialoglycans at the cell surface are not fully elucidated. Here, we generated a library of isogenic human HEK293 cells with combinatorial loss/gain of individual sialyltransferase genes and the introduction of sulfotransferases for display of the human sialome and to dissect Siglec interactions in the natural context of glycoconjugates at the cell surface. We found that Siglec-4/7/15 all have distinct binding preferences for sialylated GalNAc-type O-glycans but exhibit selectivity for patterns of O-glycans as presented on distinct protein sequences. We discovered that the sulfotransferase CHST1 drives sialoglycan binding of Siglec-3/8/7/15 and that sulfation can impact the preferences for binding to O-glycan patterns. In particular, the branched Neu5Acalpha2-3(6-O-sulfo)Galbeta1-4GlcNAc (6'-Su-SLacNAc) epitope was discovered as the binding epitope for Siglec-3 (CD33) implicated in late-onset Alzheimer's disease. The cell-based display of the human sialome provides a versatile discovery platform that enables dissection of the genetic and biosynthetic basis for the Siglec glycan interactome and other sialic acid-binding proteins.
33893239	37	42	human	Species	9606
33893239	65	71	glycan	Chemical	MESH:D011134
33893239	265	276	sialoglycan	Chemical	-
33893239	292	297	human	Species	9606
33893239	324	335	sialic acid	Chemical	MESH:D019158
33893239	383	394	glycolipids	Chemical	MESH:D006017
33893239	480	486	glycan	Chemical	MESH:D011134
33893239	680	685	human	Species	9606
33893239	686	692	HEK293	CellLine	CVCL:0045
33893239	827	832	human	Species	9606
33893239	953	966	Siglec-4/7/15	Gene	27036;284266
33893239	1020	1026	GalNAc	Chemical	-
33893239	1032	1041	O-glycans	Chemical	-
33893239	1082	1091	O-glycans	Chemical	-
33893239	1176	1181	CHST1	Gene	8534
33893239	1189	1200	sialoglycan	Chemical	-
33893239	1212	1227	Siglec-3/8/7/15	Gene	945;27181;27036;284266
33893239	1289	1297	O-glycan	Chemical	-
33893239	1336	1377	Neu5Acalpha2-3(6-O-sulfo)Galbeta1-4GlcNAc	Chemical	-
33893239	1379	1392	6'-Su-SLacNAc	Chemical	-
33893239	1444	1452	Siglec-3	Gene	945
33893239	1454	1458	CD33	Gene	945
33893239	1485	1504	Alzheimer's disease	Disease	MESH:D000544
33893239	1536	1541	human	Species	9606
33893239	Association	284266	8534
33893239	Association	27036	8534
33893239	Association	MESH:D000544	945
33893239	Association	8534	945
33893239	Association	MESH:D006017	MESH:D019158
33893239	Association	27181	8534

